Company Filing History:
Years Active: 2011
Title: Bernardo Herradon García: Innovator in Calpain Inhibition
Introduction
Bernardo Herradon García is a notable inventor based in Juan de la Cierva, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can inhibit calpain, a protease involved in various degenerative diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Herradon García holds a patent for "Isoquinoline derivatives as calpain inhibitors." This invention relates to derivative compounds of partially-reduced isoquinoline, specifically those with a sec-butyl group substitution at position 3, which exhibit calpain inhibitor activity. The inventive compound includes an ester or amide derived from (3-sec-butyl-1-oxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid and (3-sec-butyl-1-thioxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid. These compounds can be utilized in the preventive or therapeutic treatment of degenerative diseases, highlighting their potential impact on healthcare.
Career Highlights
Bernardo Herradon García is affiliated with the Consejo Superior de Investigaciones Científicas, a prestigious research institution in Spain. His work there has allowed him to focus on innovative research and development in the field of medicinal chemistry. His patent reflects his commitment to finding solutions for complex medical challenges.
Collaborations
Throughout his career, Herradon García has collaborated with esteemed colleagues, including Roberto Chicharro Martin and Vicente Jesús Aran Redo. These collaborations have fostered a productive research environment, enabling the exchange of ideas and expertise that contribute to the advancement of their shared goals.
Conclusion
Bernardo Herradon García is a distinguished inventor whose work in calpain inhibition represents a significant advancement in medicinal chemistry. His patent and collaborations underscore his dedication to improving therapeutic options for degenerative diseases. His contributions are a testament to the importance of innovation in the medical field.